Vivek Narayan
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
Papers in ⓘ
-
- Prostate Cancer Treatment and Research 25
- Renal cell carcinoma treatment 17
- Oncology 43
- Cancer Immunotherapy and Biomarkers 12
- PARP inhibition in cancer therapy 9
- CAR-T cell therapy research 8
- Co-authors
- Bonnie Ky (16 shared papers)Russell K. Pachynski (4 shared papers)Naomi B. Haas (19 shared papers)David J. Vaughn (10 shared papers)Sumit K. Subudhi (2 shared papers)Yanhua Hu (2 shared papers)Marika Ciprotti (2 shared papers)Karim Fizazi (2 shared papers)
- Journals
- Journal of Clinical Oncology (26 papers)Clinical Genitourinary Cancer (6 papers)Annals of Oncology (4 papers)Cancer (3 papers)Journal of the American College of Cardiology (3 papers)
- Partner nations
- United StatesFranceDenmark
In The Last Decade
Vivek Narayan
93 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 837
- Pulmonary and Respiratory Medicine 830
- Cancer Research 327
- Cardiology and Cardiovascular Medicine 333
- Immunology 266
Countries citing papers authored by Vivek Narayan
This map shows the geographic impact of Vivek Narayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Narayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Narayan more than expected).
Fields of papers citing papers by Vivek Narayan
This network shows the impact of papers produced by Vivek Narayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Narayan. The network helps show where Vivek Narayan may publish in the future.
Co-authors
The 25 scholars most cited alongside Vivek Narayan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 257 | |
| 2 | A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial Hit paper breakdown → | 2021 | 170 |
| 3 | 2020 | 92 | |
| 4 | 2017 | 87 | |
| 5 | 2022 | 82 | |
| 6 | 2019 | 70 | |
| 7 | 2017 | 58 | |
| 8 | 2020 | 57 | |
| 9 | 2018 | 53 | |
| 10 | 2021 | 53 | |
| 11 | 2021 | 46 | |
| 12 | 2012 | 34 | |
| 13 | 2018 | 34 | |
| 14 | 2016 | 33 | |
| 15 | 2020 | 33 | |
| 16 | 2019 | 32 | |
| 17 | 2018 | 31 | |
| 18 | 2022 | 26 | |
| 19 | 2016 | 25 | |
| 20 | 2019 | 25 |
About Vivek Narayan
Vivek Narayan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 99 papers that have together received 1.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (25 papers), Renal cell carcinoma treatment (17 papers), Cancer, Hypoxia, and Metabolism (14 papers), Chemotherapy-induced cardiotoxicity and mitigation (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), PARP inhibition in cancer therapy (9 papers), Bladder and Urothelial Cancer Treatments (8 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Oncology (837 citations), Pulmonary and Respiratory Medicine (830 citations), Cancer Research (327 citations), Cardiology and Cardiovascular Medicine (333 citations) and Immunology (266 citations). Vivek Narayan has collaborated with scholars based in United States, France and Denmark. Frequent co-authors include Bonnie Ky, Russell K. Pachynski, Naomi B. Haas, David J. Vaughn, Sumit K. Subudhi, Yanhua Hu, Marika Ciprotti, Karim Fizazi, Akash Patnaik and G. Celine Han. Their work appears in journals such as Journal of Clinical Oncology, Clinical Genitourinary Cancer, Annals of Oncology, Cancer and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.